Holy Grail of Gene Drugs, Turkey's Deadly Blasts: Saturday Wrap

  • JPMorgan research chief advises Fed to `get it over with'
  • Brazil president's main antagonist rejects calls to resign

Here are highlights of breaking news stories from around the world on Saturday:

A gene therapy treatment from a Philadelphia biotech company may be able to restore eyesight, new data shows - but at what cost?

European Central Bank President Mario Draghi said the bank’s quantitative-easing program has worked better than expected.

Twin bombings in Turkey’s capital that killed at least 95 people unleashed more chaos, with street demonstrations that were suppressed by police. It laid out in their rawest form the complex web of enemies exacerbated by the civil war in Syria.

JPMorgan Chase & Co.’s global research chief said a Federal Reserve interest-rate hike would help emerging markets and called on the Fed to “get it over with.”

Job cuts may be coming at Twitter Inc.

The head of Brazil’s lower house, the principal antagonist of President Dilma Rousseff, rejected calls by opposition parties to resign after Brazil’s three largest newspapers printed similar stories saying Swiss prosecutors have evidence he took kickbacks from a Petrobras contract.

China is planning to bar online taxi-hailing services like Uber from using private cars, and to require drivers to get special licenses and pass qualification tests.

The famed gunmaker Colt Defense LLC filed a plan of reorganization with a promise of $50 million in new financing, signaling it could be nearing an exit from bankruptcy protection.

Dish Network Corp. is embroiled in another dispute with a U.S. cable-TV provider over programming fees that has led to channels being blacked out for some customers -- this time, the issue is with Tegna Inc., the former Gannett broadcasting division.

Before it's here, it's on the Bloomberg Terminal.